MoneyWorks4Me

Indoco Remedies - Quaterly Results

01 Feb 2022 Evaluate
A fair growth of 7.78% in the revenue at Rs. 3577.60 millions was reported in the December 2021 quarter as compared to Rs. 3319.40 millions during year-ago period.A comparatively good net profit growth of 31.15% to Rs. 329.70 millions was reported for the quarter ended December 2021 compared to Rs. 251.40 millions of previous same quarter.Operating profit for the quarter ended December 2021 rose to 735.60 millions as compared to 603.30 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 3577.60 3319.40 7.78 11308.40 9354.50 20.89 12403.00 11060.00 12.14
Other Income 1.60 3.70 -56.76 20.30 11.50 76.52 31.20 24.30 28.40
PBIDT 735.60 603.30 21.93 2485.60 1701.50 46.08 2266.90 1257.70 80.24
Interest 38.10 60.30 -36.82 111.00 176.70 -37.18 222.20 262.50 -15.35
PBDT 697.50 543.00 28.45 2374.60 1524.80 55.73 2044.70 995.20 105.46
Depreciation 192.20 168.80 13.86 609.10 545.80 11.60 731.20 708.10 3.26
PBT 505.30 374.20 35.03 1765.50 979.00 80.34 1313.50 287.10 357.51
TAX 175.60 122.80 43.00 624.00 304.20 105.13 389.60 44.60 773.54
Deferred Tax 18.40 5.80 217.24 -70.00 -91.50 -23.50 4.90 44.60 -89.01
PAT 329.70 251.40 31.15 1141.50 674.80 69.16 923.90 242.50 280.99
Equity 184.30 184.30 0.00 184.30 184.30 0.00 184.30 184.30 0.00
PBIDTM(%) 20.56 18.17 13.13 21.98 18.19 20.84 18.28 11.37 60.72
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..